Source: Sky News

Yale University Professor Harvey Risch says all studies that examine the effectiveness of hydroxychloroquine on high risk population groups show the drug is “uniformly beneficial” in treating COVID-19.

“What clinicians have found around the world is that a class of people called high-risk people are the ones who need to be treated,” he said. “These are people generally over aged 60 or who have chronic conditions like diabetes, or obesity, or heart disease, high blood pressure or are immuno-compromised.

“These are people that need to be treated and the studies that look at them and them only show that hydroxychloroquine cuts the risk of hospitalisation and mortality by at least 50 per cent.” Mr Risch said there are no published studies that show the drug is not beneficial for those people.

“There are plenty of other studies that show other things but the problem is they are not looking a the right people. “All of the pushback that is against this drug has been on the basis of blurring the distinction as to who needs the drugs and who needs to be treated.”

Related: Yale prof: “The evidence in favor of hydroxychloroquine benefit in high-risk patients treated early as outpatients is stronger than anything else I’ve ever studied.”

Yale Epidemiologist: Dr. Fauci & FDA Have Caused the ‘Deaths of Hundreds of Thousands of Americans’

Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia

Pharmacy board, hydroxychloroquine and COVID-19. “It is an unusually safe drug”

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

I’ve railed against this in the media that we are a part of, and the way that the propaganda reacts to this is, “Ignore it. Ignore all of this.” I’m saying this now because the general public has to be the one that gets angry. The general public should be furious at the way people have been treated in the country by suppression of these drugs, by that kind of website that suppresses the ability of doctors to practice medicine.

Read More »

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »